Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
<< anterior 21 a 40 de 393 siguiente >>
Presentar resultados
Seleccionar todas
22.Tiene citas relacionadas Cita con resumen
Kessler C, Ward MJ, McNaughton CD. Reducing adverse drug events: the need to rethink outpatient prescribing. JAMA 2016;316:2092-3. [Ref.ID 100974]
23. Cita con resumen
Anónimo. FDA grants accelerated approval to olaratumab to treat advanced STS. DIA Daily 2016:2. [Ref.ID 100834]
24. Cita con resumen
Anónimo. FDA places hold on experimental ADHD drug. DIA Daily 2016:3. [Ref.ID 100765]
25. Cita con resumen
Anónimo. FDA approves ustekinumab for adults with moderate to severe Crohn’s. DIA Daily 2016:2. [Ref.ID 100758]
26. Cita con resumen
McCarthy M. US panel recommends depression screening for all adults. BMJ 2016;352:i573. [Ref.ID 100035]
27. Cita con resumen
Qaseem A, Barry MJ, Kansagara D, for the Clinical Guidelines Committee of the American College of Physicians. Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: A clinical practice guideline from the American College of Physicians. Ann Intern Med 2016;164:350-9. [Ref.ID 99996]
28. Cita con resumen
Shah RV, Murthy VL, Colangelo LA, Reis J, Venkatesh BA, Sharma R, Abbasi SA, GoffJr DC, Carr JJ, Rana JS, Terry JG, Bouchard C, Sarzynski MA, Eisman A, Neilan T, Das S, Jerosch-Herold M, Lewis CE, Carnethon M, Lewis GD, Lima JAC. Association of fitness in young adulthood with survival and cardiovascular risk: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA Intern Med 2016;176:87-95. [Ref.ID 99991]
29.Tiene citas relacionadas Cita con resumen
Amick HR, Gartlehner G, Gaynes BN, Forneris C, Asher GN, Morgan LC, Coker-Schwimmer E, Boland E, Lux EJ, Gaylord S, Bann C, Pierl CB, Lohr KN. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis. BMJ 2015;351:h6019. [Ref.ID 99825]
30.Tiene citas relacionadas Cita con resumen
Cox TM, Drelichman G, Cravo R, Balwani M, Burrow TA, Martins AM, Lukina E, Rosenbloom B, Ross L, Angell J, Puga AC. Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial. Lancet 2015;385:2355-62. [Ref.ID 99290]
31.Tiene citas relacionadas
Hughes DA, Pastores GM. Eliglustat for Gaucher's disease: trippingly on the tongue. Lancet 2015;385:2328-30. [Ref.ID 99287]
33. Cita con resumen
Dalsgaard S, Ostergaard D, Leckman JF, Mortensen PB, Pedersen MG. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet 2015;385:2190-6. [Ref.ID 99164]
34. Cita con resumen
Mistry PK, Lukina E, Turkia HB, Amato D, Baris H, Dasouki M, Ghosn M, Mehta A, Packman S, Pastores G, Petakov M, Assouline S, Balwani M, Danda S, Hadjiev E, Ortega A, Shankar S, Solano MH, Ross L, Angell J, Peterschmitt MJ. Effect of oral eliglustat on splenomegaly in patients with Gaucher disese type 1: the ENGAGE randomized clinical trial. JAMA 2015;313:695-706. [Ref.ID 98815]
35. Cita con resumen
Benetos A, Labat C, Rossignol P, Fay R, Rolland Y, Valbusa F, Salvi P, Zamboni M, Manckoundia P, Hanon O, Gautier S. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents.The PARTAGE Study . JAMA Intern Med 2015;175:989-95. [Ref.ID 98810]
36.Tiene citas relacionadas Cita con resumen
Hay D, Hill M, Littlewood T. Neutropenia in primary care. BMJ 2014;349:g5340. [Ref.ID 98347]
37. Cita con resumen
Anónimo. FDA approves new drug to treat a form of Gaucher disease. U.S. Food and Drug Administration 2014:19 de agosto. [Ref.ID 97855]
38.Enlace a cita original Cita con resumen
Hampton LM, Daubresse M, Chang HY, Alexander C, Budnitz DS. Emergency department visits by adults for psychiatric medication adverse events. JAMA Psychiatry 2014;71:1006-14. [Ref.ID 97739]
39. Cita con resumen
LeBlanc E, Chou R, Zakher B, Daeges M, Pappas M. Screening for vitamin D deficiency: systematic evidence review of the U.S. Preventive Services Task Force recommendation. U.S. Preventive Services Task Force 2014:junio. [Ref.ID 97711]
40.Tiene citas relacionadas Cita con resumen
Spence D. Statins for all. BMJ 2014;348:g1899. [Ref.ID 97354]
Seleccionar todas
 
<< anterior 21 a 40 de 393 siguiente >>